Verified
ICD-10 N93.9 vs N92.0: Fixing Abnormal Uterine Bleeding Specificity in Gynecology Notes
Learn how to document AUB correctly to avoid N93.9 denials. A coding specificity guide for gynecologists using N92.0 and related ICD-10 codes.


ICD-10 N93.9 Versus N92.0: Abnormal Uterine Bleeding Specificity in Gynecology Notes
Unspecified bleeding codes create exposure. When a gynecology note records only "AUB," the coder's only defensible choice is N93.9. A payer reviewing a same-day E/M and endometrial biopsy then sees a vague diagnosis attached to two billed services. This playbook from the clinical documentation team at Scribing.io explains how to document abnormal uterine bleeding so the specific code is clearly supported by the note.
Scribing.io treats this as documentation. Our Clinical-Grade Scribing engine and the Merry AI Clinical Interface record bleeding pattern, cycle regularity, and PALM-COEIN etiology during the visit. That lets coders select N92.0 (ICD-10-CM) over N93.9 (ICD-10-CM) and add D50.0 when chronic blood loss anemia is confirmed.
The N93.9 Specificity Gap
ICD-10-CM AUB Code Map
FIGO and PALM-COEIN Documentation Elements
Clinical Logic Masterclass: AUB Biopsy
Modifier 25 Audit Defense
Chrome DOM Injection Workflow Explained
Compliance and Human Attestation
Implementation Checklist for Gynecology
Frequently Asked Coding Questions
Plans and Next Steps
The N93.9 Specificity Gap in Gynecology Notes
N93.9 describes a symptom only. Its full title is "Abnormal uterine and vaginal bleeding, unspecified." In practice, it tells a payer that the clinician either did not characterize the bleeding or did not write the characterization down.
N92.0 encodes a characterized pattern. Its full title is "Excessive and frequent menstruation with regular cycle." Its inclusion terms cover heavy periods NOS, menorrhagia NOS, and polymenorrhea, so it requires the note to state volume, frequency, and regularity.
N93.9 versus N92.0: what each code tells a reviewer | ||
Dimension | N93.9 (Unspecified) | N92.0 (Specified) |
|---|---|---|
Bleeding volume | Not stated | Excessive (heavy) documented |
Cycle frequency | Not stated | Frequent (<24 days) or heavy at normal frequency |
Cycle regularity | Not stated | Regular cycle documented |
Medical necessity for biopsy | Weak; payer must infer the indication | Supported when combined with risk factors or failed therapy |
Risk adjustment and quality signal | Low specificity flag | Specific, condition-level diagnosis |
Typical audit outcome on 25-modified E/M | High denial or recoupment risk | Defensible when distinct work is documented |
Three documented facts drive selection. Coders cannot infer clinical meaning from "AUB," and ICD-10-CM guidelines prohibit them from assigning a more specific code than the provider documented. The note must answer three questions:
Is the volume excessive? State patient-perceived heaviness, pad or tampon counts, clots, and flooding.
Is the frequency abnormal? State the interval in days, for example "q18–20 days."
Is the cycle regular? State the variation between shortest and longest cycles over 6–12 months.
ICD-10-CM AUB Code Map for Outpatient Gynecology
Each code depends on documentation. The table below maps the abnormal uterine bleeding family to the clinical facts that support each code. Use it as a chart-audit reference, not as a substitute for the current tabular list. The Scribing.io ICD-10 reference library contains related specificity guides.
AUB code family and documentation triggers | ||
Code | Descriptor | Documentation Trigger |
|---|---|---|
N92.0 | Excessive and frequent menstruation with regular cycle | Heavy and/or frequent bleeding; regular cycle stated |
N92.1 | Excessive and frequent menstruation with irregular cycle | Heavy bleeding with irregular intervals or intermenstrual bleeding (menometrorrhagia) |
N92.2 | Excessive menstruation at puberty | Heavy bleeding in the pubertal or adolescent context |
N92.4 | Excessive bleeding in the premenopausal period | Heavy bleeding documented within the menopausal transition |
N92.5 / N92.6 | Other specified / unspecified irregular menstruation | Irregularity without excessive volume |
N93.0 | Postcoital and contact bleeding | Bleeding provoked by intercourse or examination |
N93.8 | Other specified abnormal uterine and vaginal bleeding | Characterized pattern not captured elsewhere |
N93.9 | Abnormal uterine and vaginal bleeding, unspecified | Pattern not documented; reserve for true information gaps |
N95.0 | Postmenopausal bleeding | Bleeding 12 or more months after final menstrual period |
D25.1 | Intramural leiomyoma of uterus | Imaging-confirmed intramural fibroid, FIGO type 3–5 location |
D50.0 | Iron deficiency anemia secondary to blood loss (chronic) | Low Hgb, low ferritin, and clinician-linked chronic menstrual loss |
D62 | Acute posthemorrhagic anemia | Acute hemorrhage; not appropriate for chronic menstrual loss |
Menopausal status changes the code. A 47-year-old with shortening cycles may be in the early menopausal transition, which points coders toward N92.4. When the patient is not in transition, the note should say so explicitly, for example with a STRAW+10 stage. That keeps N92.0 defensible.
D50.0 requires an explicit link. Coders cannot connect anemia to menstrual loss on their own. The assessment must state the causal relationship, such as "iron deficiency anemia secondary to chronic menstrual blood loss."
FIGO and PALM-COEIN Documentation Elements That Coders Need
FIGO System 1 standardizes terminology. The 2018 FIGO revision defines normal frequency as 24–38 days and normal duration as 8 days or fewer. Normal regularity is a shortest-to-longest variation of 7–9 days or less, with age-dependent thresholds. Using these parameters makes "regular" and "frequent" auditable terms rather than impressions.
FIGO System 1 parameters and their coding impact | |||
Parameter | Normal Range | Abnormal Finding | Coding Impact |
|---|---|---|---|
Frequency | 24–38 days | Frequent <24 days; infrequent >38 days | Frequent with heavy volume supports N92.0 |
Duration | ≤8 days | Prolonged >8 days | Strengthens the excessive-bleeding narrative |
Regularity | Variation ≤7–9 days | Irregular >7–9 days | Separates N92.0 from N92.1 |
Volume | Patient-perceived normal | Heavy, interfering with quality of life | Required for "excessive" in N92.x |
Intermenstrual bleeding | None | Random or cyclic IMB | Points toward N92.1 or N92.3 |
Quantify volume with pad counts. A Pictorial Blood Loss Assessment Chart (PBAC) score above 100 correlates with menstrual blood loss above 80 mL. Where PBAC is not used, document saturated products per day, overnight changes, clots larger than 2.5 cm, and episodes of flooding. These details convert "heavy" from an adjective into evidence.
PALM-COEIN explains the etiology. FIGO System 2 classifies the cause as structural (Polyp, Adenomyosis, Leiomyoma, Malignancy or hyperplasia) or non-structural (Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified). Recording the category, such as "AUB-L(O), FIGO type 4 intramural leiomyoma," supports the D25.1 code. It also documents the clinical reasoning behind the biopsy.
Leiomyoma subclassification matters clinically. Submucosal (L-SM, FIGO 0–2) and other (L-O, FIGO 3–8) fibroids carry different bleeding risks and different surgical pathways.
Coagulopathy screening belongs documented. Record the structured bleeding history screen even when it is negative, because a negative screen supports excluding AUB-C.
Ovulatory status shapes regularity. Regular frequent cycles generally argue against AUB-O and support a regular-cycle code.
Malignancy evaluation justifies biopsy. Document age, unopposed estrogen exposure, failed medical therapy, and endometrial thickness on imaging.
Clinical Logic Masterclass: Same-Day AUB E/M Plus Endometrial Biopsy
The scenario is a common one. An outpatient gynecologist evaluates a 43-year-old with abnormal uterine bleeding and performs a same-day endometrial biopsy (CPT 58100). The prior chart contains the evidence a coder needs, but it is spread across an imaging report, a lab panel, and a prior medication list.
Step One: Clinical Logic Bridge Retrieves Prior Evidence
Merry AI reads the chart. Through Chrome DOM injection, the Clinical Logic Bridge reads the EMR screens the physician already has open. It retrieves the prior evidence without a vendor API call:
Prior transvaginal ultrasound report: endometrial stripe 15 mm; intramural fibroid 4.1 cm.
Six-month bleeding history captured: polymenorrhea q18–20 days with pad counts documented.
Failed first-line medical therapy: NSAID and combined oral contraceptive trial without adequate response.
Current laboratory values retrieved: Hgb 9.3 g/dL; ferritin 8 ng/mL.
Step Two: Ambient Capture Structures the Note
Structured note excerpt, physician-attested. The following assessment is generated by Medical AI Scribing and edited and signed by the treating gynecologist.
Bleeding pattern (FIGO System 1): heavy, frequent menses q18–20 days for 6 months, duration 7 days, cycle variation 2 days (regular). Six to eight saturated pads per day on days 1–3, clots >2.5 cm, nocturnal flooding twice per cycle.
Etiology (PALM-COEIN): AUB-L(O), with a 4.1 cm intramural leiomyoma (FIGO type 4) on prior TVUS. AUB-M is under evaluation given a 15 mm endometrial stripe; coagulop

